Michael joined H&F in 2016. He is a Director of MultiPlan and is active in the Firm’s investment in Medline. He was also formerly active in the Firm’s investment in Pharmaceutical Product Development. Prior to H&F, Michael worked at Morgan Stanley in New York as an Investment Banking Analyst in their Mergers and Acquisitions Group.